You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...
Citron Research’s tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company’s stock to fall as much as 9 percent ...
ST. LOUIS -- Shares of Express Scripts Inc., among the nation's largest pharmacy benefit managers, extended their 52-week high on Friday, courtesy of its expectations of a better-than-expected first ...
Carl Icahn rattled the health care industry on Wednesday. Icahn, an activist investor, built a sizable stake in health insurer Cigna, the Wall Street Journal reported. Cigna is in the process of ...
Total spending on health care in the United States is expected to climb from $3 trillion to over $4 trillion annually by the end of the decade, and while that may mean sales growth for a lot of health ...
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, pharmacy benefit manager Express Scripts has earned a respected ...
Valeant Pharmaceuticals Inc. sustained hits on several fronts on Thursday after CVS Health Corp. and Express Scripts dropped Philidor from their networks in a sign the fallout from the drugmaker's ...
June 19 (Reuters) - UBS downgraded two major U.S. pharmacy benefit managers, saying potential benefits from the launch of a generic version of Pfizer Inc's blockbuster cholesterol drug Lipitor were ...
Express Scripts director Dr. Woodrow Myers Jr. exercised stock options for 7,128 shares worth $30.83. Myers sold those shares for $64.66 on Sept. 4, which earned him $241,140 after paying to exercise ...
Last year was blah for Express Scripts Holding Company shareholders. The giant pharmacy benefit manager's stock turned in 3% gain -- well below the 21% jump from the previous year. After just a few ...
NEW YORK (Reuters) - Express Scripts Inc. on Tuesday launched a $24.8 billion offer for Caremark Rx Inc. , the latest step in a high-stakes takeover battle after Caremark last week said it preferred a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results